1. Home
  2. CCO vs KROS Comparison

CCO vs KROS Comparison

Compare CCO & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCO
  • KROS
  • Stock Information
  • Founded
  • CCO 1995
  • KROS 2015
  • Country
  • CCO United States
  • KROS United States
  • Employees
  • CCO N/A
  • KROS 163
  • Industry
  • CCO Advertising
  • KROS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CCO Consumer Discretionary
  • KROS Health Care
  • Exchange
  • CCO Nasdaq
  • KROS Nasdaq
  • Market Cap
  • CCO 586.1M
  • KROS 558.9M
  • IPO Year
  • CCO 2005
  • KROS 2020
  • Fundamental
  • Price
  • CCO $1.22
  • KROS $13.35
  • Analyst Decision
  • CCO Buy
  • KROS Buy
  • Analyst Count
  • CCO 4
  • KROS 13
  • Target Price
  • CCO $1.88
  • KROS $20.63
  • AVG Volume (30 Days)
  • CCO 5.1M
  • KROS 620.1K
  • Earning Date
  • CCO 08-06-2025
  • KROS 08-06-2025
  • Dividend Yield
  • CCO N/A
  • KROS N/A
  • EPS Growth
  • CCO N/A
  • KROS N/A
  • EPS
  • CCO N/A
  • KROS 0.11
  • Revenue
  • CCO $1,512,570,000.00
  • KROS $214,713,000.00
  • Revenue This Year
  • CCO $5.10
  • KROS $5,006.76
  • Revenue Next Year
  • CCO $3.29
  • KROS N/A
  • P/E Ratio
  • CCO N/A
  • KROS $123.16
  • Revenue Growth
  • CCO 14.28
  • KROS 91657.70
  • 52 Week Low
  • CCO $0.81
  • KROS $9.12
  • 52 Week High
  • CCO $1.88
  • KROS $72.37
  • Technical
  • Relative Strength Index (RSI)
  • CCO 63.48
  • KROS 43.06
  • Support Level
  • CCO $1.09
  • KROS $13.41
  • Resistance Level
  • CCO $1.20
  • KROS $13.99
  • Average True Range (ATR)
  • CCO 0.05
  • KROS 0.44
  • MACD
  • CCO 0.01
  • KROS -0.07
  • Stochastic Oscillator
  • CCO 96.43
  • KROS 9.84

About CCO Clear Channel Outdoor Holdings Inc.

Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: